Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659893 · ClinicalTrials.gov registry record · Phase 1
Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
A Phase 1 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT00659893 is a Phase 1 study that has completed, run by Peplin. The registered enrollment target is 64 participants.
The verdict
NCT00659893, a Phase 1 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
Study Hypothesis: Safety and Tolerability will differ when treating multiple contiguous 25 cm2 treatment areas, as compared to individual 25 cm2 treatment areas.
Interventions
- DRUG PEP005 Topical gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00659893
The ClinicalTrials.gov registry entry for NCT00659893 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEP005 Topical gel is the first listed.
NCT00659893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00659893 about?
NCT00659893 is a clinical study titled "Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2". Study Hypothesis: Safety and Tolerability will differ when treating multiple contiguous 25 cm2 treatment areas, as compared to individual 25 cm2 treatment areas.
What is the current status of trial NCT00659893?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2008-04. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00659893?
The interventions under investigation include: PEP005 Topical gel (DRUG).
Who is sponsoring clinical trial NCT00659893?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.